194 related articles for article (PubMed ID: 27852659)
1. Case of Steven-Johnson Syndrome in a male with breast cancer secondary to docetaxel/cyclophosphamide therapy.
Jarrett B; Ghazala S; Chao J; Chaudhary S
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27852659
[TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis as adjuvant therapy in Stevens-Johnson syndrome and hepatic encephalopathy.
Hung PC; Wang HS; Hsia SH; Wong AM
Brain Dev; 2014 Apr; 36(4):356-8. PubMed ID: 23777679
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel induced Lyell's syndrome: a rare life threatening cause of dermatitis medicamentosas.
Arshad F; Bhat TS; Lone AR
J Cancer Res Ther; 2014; 10(3):742-4. PubMed ID: 25313773
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
5. Severe pneumonia caused by combined infection with Pneumocystis jiroveci, parainfluenza virus type 3, cytomegalovirus, and Aspergillus fumigatus in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Lee T; Bae YJ; Park SK; Park HJ; Kim SH; Cho YS; Moon HB; Lee SO; Kim TB
Acta Derm Venereol; 2010 Nov; 90(6):625-9. PubMed ID: 21057748
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of toxic epidermal necrolysis using plasmapheresis: A prospective observational study.
Han F; Zhang J; Guo Q; Feng Y; Gao Y; Guo L; Hou Y; An J; Wang X; Yan B; Zheng Y; Song J; Li M; Wang G
J Crit Care; 2017 Dec; 42():65-68. PubMed ID: 28688239
[TBL] [Abstract][Full Text] [Related]
9. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review.
Canavan TN; Mathes EF; Frieden I; Shinkai K
J Am Acad Dermatol; 2015 Feb; 72(2):239-45. PubMed ID: 25592340
[TBL] [Abstract][Full Text] [Related]
10. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
11. Mycoplasma-Induced Rash and Mucositis or Steven-Johnson Syndrome.
Thangaraju S; Bagri N; Gupta V; Sinha A
Indian J Pediatr; 2021 Aug; 88(8):802-804. PubMed ID: 33447929
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome/toxic epidermal necrolysis.
Baker MG; Cresce ND; Ameri M; Martin AA; Patterson JW; Kimpel DL
J Clin Rheumatol; 2014 Apr; 20(3):167-71. PubMed ID: 24662561
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
Worswick S; Cotliar J
Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
16. [A case of Stevens-Johnson syndrome (SJS) progressive toxic epidermal necrolysis (TEN) onset during hyposensitization therapy for pulmonary tuberculosis complicated with dermatomyositis].
Yamashita H; Ueda Y; Takahashi Y; Mimori A
Kansenshogaku Zasshi; 2012 Jul; 86(4):419-24. PubMed ID: 22991850
[TBL] [Abstract][Full Text] [Related]
17. [Toxic epidermal necrolysis (drug-induced Lyell's syndrome). 2. Treatment].
Konstantinow A; Mühlbauer W; Balda BR; Ring J
Dtsch Med Wochenschr; 2001 Feb; 126(7):177-9. PubMed ID: 11236525
[No Abstract] [Full Text] [Related]
18. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
Teo L; Tay YK; Liu TT; Kwok C
Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
[TBL] [Abstract][Full Text] [Related]
19. Mucositis, conjunctivitis but no rash - the "Atypical Stevens - Johnson syndrome".
McGouran DC; Petterson T; McLaren JM; Wolbinski MP
Acute Med; 2011; 10(2):81-2. PubMed ID: 22041607
[TBL] [Abstract][Full Text] [Related]
20. The management of toxic epidermal necrolysis.
Fernando SL
Australas J Dermatol; 2012 Aug; 53(3):165-71. PubMed ID: 22881464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
